Brief: Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial
27/10/2025 13:47
Oct 27 (Reuters) - Orchestra Biomed Holdings Inc OBIO.O: ORCHESTRA BIOMED ANNOUNCES FIRST PATIENTS ENROLLED IN VIRTUE® SAB US PIVOTAL IDE CORONARY TRIAL Source text: ID:nGNX4VRc4W Further company coverage: OBIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchestra Biomed Holdings
See all newsBrief: Orchestra Biomed Announces Pricing Of Public Offering
Orchestra BioMed slides after starting equity offering
Brief: Orchestra Biomed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Orchestra Biomed Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Orchestra BioMed Q2 revenue drops, net loss widens